Doxylamine Succinate and Pyridoxine Hydrochloride

Therapeutic Indication:

Bonjesta® is an FDA-approved prescription medication indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. It is designed to be a fast-acting, long-lasting treatment of morning sickness when diet and lifestyle changes do not work. Bonjesta®’s multilayer, extended-release tablets are designed to provide rapid and continuous relief of morning sickness symptoms throughout the day and night.

  • Composition: Doxylamine Succinate 20 mg, Pyridoxine (VIT B6) Hydrochloride 20 mg.
  • Pharmaceutical Form: Tablet.
  • Method of Administration: Oral.
  • How Supplied: Box of 50 tablets, 5 blister packs.
  • Manufacturer: Duchesnay, Canada.

Contact Us

Contact us today to find out more about our services and discuss your enquiries.